53 stories
All topics
For 15 years, the Hackney Mosaic Project in East London has turned broken tiles into vibrant public art while offering therapeutic refuge to volunteers living with depression, addiction and PTSD. Founder Tessa Hunkin says the work gives people "a holiday from their head."
In a UK-led trial, colon cancer patients with a specific genetic subtype who received just nine weeks of the immunotherapy pembrolizumab before surgery have stayed cancer-free for nearly three years, with zero relapses so far.
In a São Paulo State University trial, 43% of women taking 2,000 IU vitamin D daily alongside neoadjuvant chemotherapy saw their breast cancer disappear, versus 24% on placebo — an inexpensive boost worth larger trials.
In April 2026, the FDA approved Otarmeni, the first gene therapy for inherited hearing loss caused by OTOF gene variants. In the CHORD trial, 16 of 20 patients met the hearing-improvement endpoint, and Regeneron will offer it free in the US.
A UCL and Great Ormond Street Hospital study found that the gene therapy Luxturna can strengthen the visual pathways of young children with inherited blindness, with the greatest gains when treatment comes early in brain development.
A meta-analysis of over 4 million people, published in Nature Mental Health in April 2026, found that higher cardiorespiratory fitness was linked to a 36% lower risk of depression and a 39% lower risk of dementia — with even small gains helping.
The Breakthrough Prize Foundation awarded six $3 million prizes on April 18, 2026, recognizing pioneers who restored sight through gene therapy, cured sickle cell disease and mapped the genetic roots of ALS.
A landmark study published in Nature Mental Health in April 2026 drew on 122 experts across 11 disciplines to reach the first international consensus on positive mental wellbeing, identifying six essential elements.
Italian researchers used AI to design "Apt1," a novel molecule that disrupts DNA repair in pancreatic cancer cells, making tumors significantly more responsive to chemotherapy while sparing healthy cells.
Researchers at Karolinska Institutet treated ten patients with a single injection delivering a working OTOF gene to the inner ear, with all showing clear hearing improvement within six months.
In a world first, researchers have used generative AI to design synthetic DNA molecules capable of controlling gene expression in healthy mammalian cells, opening new frontiers for precision cancer therapy.
FDA approval of elinzanetant (Lynkuet) marks a breakthrough in menopause care, offering women effective relief from hot flashes and night sweats without the risks of hormone replacement therapy.
Scientists have used AI to design smart DNA-based drugs that can identify and target cancer cells with extreme precision while leaving healthy cells untouched, potentially transforming cancer treatment by minimizing the devastating side effects of conventional chemotherapy.
Portugal's nationwide program placing mental health professionals in every public school has reported a 35% decrease in teen anxiety and a 40% reduction in crisis interventions after its first full year of operation.
Philadelphia's LandCare program, run by the Pennsylvania Horticultural Society, has cleared and greened 12,000 vacant lots — a third of the city's vacant land. Research links the greened sites to a 29 percent drop in gun violence, a 21 percent drop in burglary and a 41.5 percent drop in nearby depression.
Researchers at Karolinska Institutet and partners in China restored hearing in all ten patients with a rare genetic deafness using a single gene-therapy injection, with much of the improvement appearing within a month.
A New England Journal of Medicine study reported in 2026 found that reni-cel, a one-time CRISPR-Cas12a gene-editing therapy, ended painful vaso-occlusive crises in 27 of 28 patients with severe sickle cell disease and normalized their hemoglobin.
A large study finds that GLP-1 medications like semaglutide offer unexpected mental health benefits alongside weight loss, with significant reductions in depression, anxiety, and psychiatric-related conditions among patients.
In March 2026, the FDA approved Kresladi, the first gene therapy for children with severe leukocyte adhesion deficiency type I. In the trial led partly at UCLA, all nine treated patients survived without a bone-marrow transplant.
On 25 March 2026, the FDA approved Avlayah, the first biologic engineered to cross the blood-brain barrier to treat the neurological effects of Hunter syndrome — a rare childhood disorder — after a trial showed a 91% drop in a key disease marker in the brain.
Compass Pathways reported positive results from Phase 3 trials of COMP360, a synthetic psilocybin treatment for depression, potentially making it the first psilocybin-based medication approved in the U.S.
CNN Hero Heidi Karman founded First Responder Therapy Dogs to address the mental health crisis among firefighters, paramedics, and police officers. Since 2021, her organization has certified over 500 therapy-dog teams across 46 states, supporting more than 150,000 first responders in managing chronic stress and trauma.
A UC Davis-led clinical trial has safely performed the world's first spina bifida treatment combining fetal surgery with placenta-derived stem cells, with all six infants born with intact repair sites and reversed brain abnormalities.
After withdrawing from most events at Tokyo 2021 to prioritize her mental health, Simone Biles returned triumphantly at the 2024 Paris Olympics, winning three gold medals and one silver to become the most decorated Olympic gymnast in history.
A landmark study shows therapy dog visits reduce patient pain scores by 25% and cut anxiety medication use in half, leading to rapid hospital adoption.
Researchers at Case Western Reserve University have discovered that natural killer (NK) cells taken from HIV-positive patients can be enhanced in the lab to target and reduce viral reservoirs — a breakthrough that could one day free millions from daily antiretroviral medications.
The gene-editing therapy Casgevy is now accessible in 30 nations including Nigeria and India, where sickle-cell disease is most prevalent.
On 17 February 2026, Compass Pathways reported that its second Phase 3 trial of COMP360 psilocybin met its primary endpoint, with a single 25 mg dose significantly reducing symptoms of treatment-resistant depression and rapid onset from the next day.
UK doctors have reported a breakthrough in treating Huntington's disease, with a new gene therapy able to slow its progression by 75 percent. The treatment targets the faulty gene responsible for the devastating neurodegenerative condition that affects around 30,000 people in the UK alone.
The smartphone-free childhood movement caught on globally in 2025, with parents forming local groups, schools implementing phone-free policies, and governments exploring legislation. The movement reflects growing awareness that children's wellbeing improves significantly when screen time is moderated.
Verified report based on cited source.
A global trial led by Wake Forest, published in The Lancet Haematology in February 2026, found that ropeginterferon alfa-2b outperformed standard therapy for high-risk essential thrombocythemia patients who cannot tolerate hydroxyurea.
A comprehensive study shows that personalized music therapy can reduce chronic pain perception by up to 50%, offering a drug-free alternative for millions of sufferers.
A Yorkshire therapist has discovered her intuitive flock of sheep has an unexpected ability to help people unload their worries and find emotional healing.
The new 988 Suicide & Crisis Lifeline handled over 5 million calls, texts, and chats in its first year, with teens being the fastest-growing group seeking help.
After years of budget cuts, school theater programs are experiencing a renaissance as research confirms their powerful impact on student mental health and social skills.
New research shows that lead pollution in the United States has decreased by a factor of 100 over the past century, marking a major environmental health victory.
UK doctors report a breakthrough in treating Huntington's disease, with a new gene therapy able to slow its progression by 75 percent.
Revolutionary gene therapy treatment has successfully helped people born with genetic hearing loss to recover some of their hearing, marking a new era in treating hereditary deafness.
A baby girl with a rare and fatal genetic disorder became the first person to receive a personalized CRISPR-based gene therapy, and is now thriving months after treatment.
A comprehensive study has found that well-designed mental health apps can be as effective as traditional therapy for treating mild to moderate depression and anxiety.
Surf therapy programs for military veterans are showing remarkable mental health improvements, with participants reporting significant reductions in PTSD symptoms.
Therapy sheep are providing comfort and helping people manage stress and anxiety, proving that animal-assisted therapy can take many forms.
A groundbreaking new therapy is offering hope to patients with blood cancers previously considered untreatable, showing remarkable results in clinical trials.
Simone Biles, the most decorated gymnast in history with 37 World and Olympic medals, received the Presidential Medal of Freedom in 2025. The honor recognizes not only her athletic achievements but also her advocacy for mental health in sports.
A Cochrane review of 73 trials found that moderate-intensity exercise may be as effective at reducing depression symptoms as therapy and antidepressants.
In December 2025, the FDA approved mitapivat (AQVESME), the first oral disease-modifying treatment for anemia in adults with alpha- or beta-thalassemia, after two Phase 3 trials showed it improved hemoglobin and reduced transfusion needs.
The FDA cleared Flow Neuroscience's FL-100, a wearable headset delivering gentle electrical stimulation to treat major depression at home, the first device of its kind authorized in the US as a non-drug therapy.
A systematic review of 104 studies across 22 countries, published in late 2025 and named the Nutrition Society’s Paper of the Month, found that closer adherence to a Mediterranean diet was consistently linked to lower depression, anxiety and stress.
In a historic medical breakthrough, gene therapy has been used to significantly slow Huntington's disease for the first time.
The Healthy Minds Study found that depression, anxiety and suicidal thoughts among US college students declined for a third straight year, offering a hopeful counter-narrative on youth mental health.
A New England Journal of Medicine trial found that zimislecel, a stem-cell-derived islet therapy, freed 10 of 12 type 1 diabetes patients from insulin injections at one year, with all avoiding severe low-blood-sugar events.
The FDA-approved CRISPR therapy Casgevy has successfully cured sickle cell disease patients, with many now living pain-free after a single treatment.
